Buloxibutid is a first-in-class angiotensin II type 2 (AT2) receptor agonist that activates ... Approval and Priority Review. The Phase 2b ASPIRE trial to assess the safety and efficacy of ...

(G) Gastric adenocarcinoma, surgical resection from primary lesion. (H) Tumor cells show strong (3+) membrane staining (arrows) with FGFR2b. FGFR2b, fibroblast growth factor receptor 2 isoform IIIb; H ...

such as toll-like receptors (TLRs), Fc gamma receptors (FcγRs), and CD40L, which enable them to detect pathogens and participate in innate and adaptive immunity. MKs also phagocytose fungi and ...